PURE (PURE Bioscience) FCF Margin %: -92.49% (As of Apr. 2026)


What is PURE Bioscience FCF Margin %?

PURE Bioscience PURE -4.67% FCF Margin % is -92.49% as of Apr. 2026. The stock has 5 warning signs investors should review. Among 1,955 Consumer Packaged Goods companies, PURE Bioscience ranks worse than 95.75% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. PURE Bioscience's Free Cash Flow for the three months ended in Apr. 2026 was $-0.47 Mil. PURE Bioscience's Revenue for the three months ended in Apr. 2026 was $0.51 Mil. Therefore, PURE Bioscience's FCF Margin % for the quarter that ended in Apr. 2026 was -92.49%.

As of today, PURE Bioscience's current FCF Yield % is -20.52%.

The historical rank and industry rank for PURE Bioscience's FCF Margin % or its related term are showing as below:

PURE' s FCF Margin % Range Over the Past 10 Years
Min: -418.62   Med: -146.09   Max: 8.83
Current: -73.49


During the past 13 years, the highest FCF Margin % of PURE Bioscience was 8.83%. The lowest was -418.62%. And the median was -146.09%.

PURE's FCF Margin % is ranked worse than
95.75% of 1955 companies
in the Consumer Packaged Goods industry
Industry Median: 2.15 vs PURE: -73.49


PURE Bioscience FCF Margin % Related Terms


PURE Bioscience FCF Margin % Historical Data

* Premium members only.

The historical data trend for PURE Bioscience's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PURE Bioscience FCF Margin % Chart

PURE Bioscience Annual Data
Trend Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -42.98 -134.86 -176.40 -128.94 -91.51

PURE Bioscience Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -104.28 -59.69 -35.31 -136.49 -92.49

PURE vs RAY, DSY, TANH: FCF Margin % Comparison

For the Household & Personal Products subindustry, PURE Bioscience's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PURE Bioscience FCF Margin % vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, PURE Bioscience's FCF Margin % distribution charts can be found below:

* The bar in red indicates where PURE Bioscience's FCF Margin % falls into.



PURE Bioscience FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

PURE Bioscience's FCF Margin for the fiscal year that ended in Jul. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Jul. 2025 )/Revenue (A: Jul. 2025 )
=-2.015/2.202
=-91.51 %

PURE Bioscience's FCF Margin for the quarter that ended in Apr. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Apr. 2026 )/Revenue (Q: Apr. 2026 )
=-0.468/0.506
=-92.49 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -92.49% mean?
PURE Bioscience (PURE) has a FCF Margin % of -92.49% as of Apr. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on PURE Bioscience and its competitors. According to the industry distribution chart, PURE Bioscience ranks #1872 out of 1955 companies in the Consumer Packaged Goods industry, placing it in the top 95.8%.
Is PURE Bioscience's FCF Margin % too high?
PURE Bioscience's current FCF Margin % is -92.49%. Based on the distribution chart, PURE Bioscience ranks #1872 out of 1955 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers.
How does PURE Bioscience's FCF Margin % compare to RAY and DSY?
According to the Consumer Packaged Goods industry distribution chart, PURE Bioscience ranks #1872 out of 1955 companies for FCF Margin %. This places PURE Bioscience in the lower half of its industry. The industry median FCF Margin % is 2.15. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Consumer Packaged Goods company?
The median FCF Margin % among Consumer Packaged Goods companies is 2.15, based on 1,955 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on PURE Bioscience and its competitors. For the Consumer Packaged Goods industry, the median FCF Margin % is 2.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PURE Bioscience's current FCF Margin % is -92.49%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PURE Bioscience stock overvalued right now?
Based on GuruFocus' analysis, PURE Bioscience (PURE) is currently considered Possible Value Trap. The stock's GF Value™ is $0.10, compared to a current price of $0.07 — trading 33.3% below its estimated fair value. The current FCF Margin % is -92.49%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For PURE Bioscience (PURE), the current FCF Margin % is -92.49% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PURE Bioscience Business Description

Address 771 Jamacha Road, No. 512, El Cajon, CA, USA, 92019
PURE Bioscience Inc is engaged in developing and commercializing proprietary antimicrobial products. The company's technology platform is based on patented stabilized ionic silver, and its initial products contain silver dihydrogen citrate, or SDC. It offers PURE Hard Surface as a food contact surface sanitizer and disinfectant to restaurant chains, food processors and food transportation companies and PURE Control as a direct food contact processing aid. It also manufactures and sells SDC-based products for end use, and products preserved with SDC and SDC as a raw material ingredient for manufacturing use. The company generates revenue from the sale of its antimicrobial products.